Biodesix Inc. (BDSX)
1.14
0.01 (0.88%)
At close: Jan 15, 2025, 11:53 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -52.15M | -65.45M | -43.16M | -31.35M | -30.73M | -26.17M |
| Depreciation & Amortization | 5.51M | 5.84M | 3.18M | 2.90M | 2.79M | 1.74M |
| Stock-Based Compensation | 5.37M | 5.96M | 4.94M | 3.71M | 170.00K | 142.00K |
| Other Working Capital | 15.34M | -2.98M | -6.86M | 5.51M | 791.00K | 446.00K |
| Other Non-Cash Items | 7.09M | 13.01M | 4.33M | 6.58M | 5.32M | 6.31M |
| Deferred Income Tax | n/a | n/a | -2.10M | 1.60M | 2.36M | 47.00K |
| Change in Working Capital | 11.30M | -4.34M | 4.59M | -4.80M | -1.65M | 253.00K |
| Operating Cash Flow | -22.87M | -44.97M | -28.22M | -21.37M | -21.73M | -17.68M |
| Capital Expenditures | -23.06M | -3.53M | -2.55M | -2.18M | -1.42M | -617.00K |
| Acquisitions | n/a | n/a | n/a | -750.00K | -456.00K | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -143.00K | -236.00K | -306.00K | -232.00K | -106.00K | -119.00K |
| Investing Cash Flow | -23.06M | -3.53M | -2.55M | -2.93M | -1.87M | -617.00K |
| Debt Repayment | 9.95M | 16.50M | -15.35M | 16.04M | 13.04M | -12.65M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -8.95M | -17.15M | 269.00K | -6.91M | 19.93M | 31.68M |
| Financial Cash Flow | 29.13M | 58.88M | 1.26M | 81.13M | 22.97M | 19.03M |
| Net Cash Flow | -16.80M | 10.38M | -29.51M | 56.84M | -626.00K | 738.00K |
| Free Cash Flow | -45.93M | -48.51M | -30.77M | -23.54M | -23.14M | -18.29M |